| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |